nomlabofusp — NDA/BLA submission
2H 2026
Rolling BLA Submission: Completion expected 2H 2026 of submission seeking accelerated approval.Source filing
LARIMAR THERAPEUTICS INC · Data as of 2026-09-08
2H 2026
Rolling BLA Submission: Completion expected 2H 2026 of submission seeking accelerated approval.Source filing